SeaCrest Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,918
| Closed | -$211K | – | 628 |
|
2024
Q1 | $211K | Sell |
4,918
-1,674
| -25% | -$71.8K | 0.03% | 553 |
|
2023
Q4 | $258K | Sell |
6,592
-19,532
| -75% | -$766K | 0.03% | 500 |
|
2023
Q3 | $947K | Buy |
26,124
+673
| +3% | +$24.4K | 0.12% | 174 |
|
2023
Q2 | $907K | Sell |
25,451
-1,770
| -7% | -$63.1K | 0.11% | 186 |
|
2023
Q1 | $969K | Buy |
27,221
+1,273
| +5% | +$45.3K | 0.13% | 176 |
|
2022
Q4 | $912K | Sell |
25,948
-1,588
| -6% | -$55.8K | 0.13% | 183 |
|
2022
Q3 | $810K | Buy |
+27,536
| New | +$810K | 0.12% | 184 |
|
2022
Q2 | – | Sell |
-32,794
| Closed | -$1.79M | – | 1628 |
|
2022
Q1 | $1.79M | Sell |
32,794
-364
| -1% | -$19.8K | 0.21% | 99 |
|
2021
Q4 | $1.83M | Sell |
33,158
-10,529
| -24% | -$580K | 0.2% | 96 |
|
2021
Q3 | $2.09M | Buy |
43,687
+15,698
| +56% | +$750K | 0.25% | 76 |
|
2021
Q2 | $1.39M | Buy |
27,989
+1,201
| +4% | +$59.8K | 0.17% | 123 |
|
2021
Q1 | $1.2M | Sell |
26,788
-1,767
| -6% | -$78.8K | 0.16% | 136 |
|
2020
Q4 | $1.31M | Sell |
28,555
-4,935
| -15% | -$227K | 0.18% | 117 |
|
2020
Q3 | $1.58M | Sell |
33,490
-340
| -1% | -$16K | 0.25% | 86 |
|
2020
Q2 | $1.73M | Buy |
33,830
+2,458
| +8% | +$125K | 0.3% | 73 |
|
2020
Q1 | $1.49M | Sell |
31,372
-943
| -3% | -$44.7K | 0.32% | 72 |
|
2019
Q4 | $1.9M | Buy |
32,315
+4,749
| +17% | +$279K | 0.32% | 71 |
|
2019
Q3 | $1.47M | Buy |
27,566
+1,560
| +6% | +$83.2K | 0.28% | 82 |
|
2019
Q2 | $1.3M | Buy |
26,006
+1,316
| +5% | +$65.8K | 0.26% | 84 |
|
2019
Q1 | $1.29M | Buy |
24,690
+1,140
| +5% | +$59.6K | 0.22% | 96 |
|
2018
Q4 | $1.13M | Buy |
23,550
+11,572
| +97% | +$553K | 0.23% | 90 |
|
2018
Q3 | $601K | Buy |
11,978
+312
| +3% | +$15.7K | 0.1% | 217 |
|
2018
Q2 | $588K | Buy |
11,666
+680
| +6% | +$34.3K | 0.11% | 214 |
|
2018
Q1 | $537K | Buy |
10,986
+1,915
| +21% | +$93.6K | 0.1% | 226 |
|
2017
Q4 | $402K | Buy |
+9,071
| New | +$402K | 0.07% | 293 |
|